Protein tyrosine phosphatase 1B (PTP1B) is a protein tyrosine phosphatase of unknown function, although increasing evidence supports a role for this phosphatase in insulin action. We have investigated the interaction of PTP1B with the insulin receptor using a PTP1B glutathione S-transferase (GST) fusion protein with a point mutation in the enzyme's catalytic domain. This fusion protein is catalytically inactive, but the phosphatase's phosphotyrosine binding site is maintained. The activated insulin receptor was precipitated from purified receptor preparations and whole-cell lysates by the inactive PTP1B-GST, demonstrating a direct association between the insulin receptor and PTP1B. A p120 of unknown identity was also precipitated from whole-cell lysates by the PTP1B fusion protein, but IRS-1 (pp185) was not. A catalytically inactive [35S]PTP1B-fusion protein bound directly to immobilized insulin receptor kinase domains and was displaced in a concentration-dependent manner. Finally, tyrosine-phosphorylated PTP1B was precipitated from whole-cell lysates by an anti-insulin receptor antibody after insulin stimulation. The site of interaction between PTP1B and the insulin receptor was studied using phosphopeptides modeled after the receptor's kinase domain, the NPXY domain, and the COOH-terminal. Each phosphopeptide inhibited the PTP1B-GST:insulin receptor interaction. Study of mutant insulin receptors demonstrated that activation of the kinase domain is necessary for the PTP1B:insulin receptor interaction, but receptors with deletion of the NPXY domain or of the COOH-terminal can still bind to the PTP1B-GST. We conclude that PTP1B can associate directly with the activated insulin receptor at multiple different phosphotyrosine sites and that dephosphorylation by PTP1B may play a significant role in insulin receptor signal transduction.
Skip Nav Destination
Article navigation
Original Articles|
October 01 1996
Protein Tyrosine Phosphatase 1B Interacts With the Activated Insulin Receptor
B Lynn Seely;
B Lynn Seely
Department of Medicine, University of California, Division of Endocrinology and Metabolism, University of California
San Diego, La Jolla, California
Search for other works by this author on:
Patricia A Staubs;
Patricia A Staubs
Department of Medicine, University of California, Division of Endocrinology and Metabolism, University of California
San Diego, La Jolla, California
Search for other works by this author on:
Donna R Reichart;
Donna R Reichart
Department of Medicine, University of California, Division of Endocrinology and Metabolism, University of California
San Diego, La Jolla, California
Search for other works by this author on:
Paulos Berhanu;
Paulos Berhanu
Department of Medicine, University of California, Division of Endocrinology and Metabolism, University of California
San Diego, La Jolla, California
Search for other works by this author on:
Kim L Milarski;
Kim L Milarski
Veterans Administration Medical Center, Medical Research Service, Whittier Diabetes Program
San Diego, California, La Jolla
Department of Medicine, University of Colorado Health Sciences Center
Denver, Colorado
Department of Signal Transduction, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company
Ann Arbor, Michigan
Search for other works by this author on:
Alan R Saltiel;
Alan R Saltiel
Veterans Administration Medical Center, Medical Research Service, Whittier Diabetes Program
San Diego, California, La Jolla
Department of Medicine, University of Colorado Health Sciences Center
Denver, Colorado
Department of Signal Transduction, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company
Ann Arbor, Michigan
Search for other works by this author on:
Jyotirmoy Kusari;
Jyotirmoy Kusari
Department of Physiology, School of Medicine, Tulane University Medical Center
New Orleans, Lousiana
Search for other works by this author on:
Jerrold M Olefsky
Jerrold M Olefsky
Department of Medicine, University of California, Division of Endocrinology and Metabolism, University of California
San Diego, La Jolla, California
Search for other works by this author on:
Address correspondence and reprint requests to Dr. B. Lynn Seely, 9500 Gilman Dr. (0673), La Jolla, CA 92093.
Diabetes 1996;45(10):1379–1385
Article history
Received:
July 20 1995
Revision Received:
May 08 1996
Accepted:
May 08 1996
PubMed:
8826975
Citation
B Lynn Seely, Patricia A Staubs, Donna R Reichart, Paulos Berhanu, Kim L Milarski, Alan R Saltiel, Jyotirmoy Kusari, Jerrold M Olefsky; Protein Tyrosine Phosphatase 1B Interacts With the Activated Insulin Receptor. Diabetes 1 October 1996; 45 (10): 1379–1385. https://doi.org/10.2337/diab.45.10.1379
Download citation file:
201
Views